Pharmaceutical Analytical Testing Market Size Projected to Reach $15.12 billion by 2034 | 7.15%

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

According to Straits Research, the global pharmaceutical analytical testing market size was valued at $8.13 billion in 2025 and is projected to reach $15.12 billion by 2034, at a CAGR of 7.15% during the forecast period 2026–2034.

Straits Research, a leading market research organization, announced the release of the report titled Pharmaceutical Analytical Testing Market Size and Outlook-Forecast till 2034. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to Straits Research, the global pharmaceutical analytical testing market size was valued at $8.13 billion in 2025 and is projected to reach $15.12 billion by 2034, at a CAGR of 7.15% during the forecast period 2026–2034. The pharmaceutical analytical testing market is segmented based on service type, end user, and region. Some of the insights provided in the report are highlighted below:

• The microbial testing segment is expected to register a CAGR of 7.94% during the forecast period.
• North America is expected to lead the market during the forecast period, owing to the strong presence of leading pharmaceutical companies and the widespread availability of high-end analytical platforms, such as LC-MS, HPLC, and bioassays.
• Biopharma companies are increasingly outsourcing analytical testing to reduce costs and access specialized platforms.
• South Africa is expected to lead the Middle East and Africa pharmaceutical analytical testing due to increasing investments in advanced laboratory infrastructure.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

The contents of the report are as follows:

By Service Type

• Bioanalytical Testing
• Method Development and Validation
• Stability Testing
• Drug Substances Testing
• Microbial Testing
• Physical Characterization
• Other Services

By End User

• Pharmaceutical Companies
• Biopharmaceutical Companies
• CROs & CDMOs
• Academic & Research Institutes

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa